Finland

CurifyLabs raises €12M Series A to expand personalised Medicine Platform into the US
CurifyLabs, a Finnish health technology company developing automated compounding systems for personalised medicines, has raised €12M in a Series A round co-led by Sandwater and HealthCap, with participation from Tesi, existing investor Lifeline Ventures, and a number of US-based customers and employees.

The best Articles in our Network